Nyrada Inc – 2022 AGM Letter to Shareholders and Proxy

Sydney, 18 October 2022: Nyrada Inc (ASX: NYR) (“Nyrada” or “the Company”) a preclinical stage, drug development company specialising in novel small molecule drugs to treat cardiovascular and neurological diseases, attaches the following documents in relation to FY2022 Annual General Meeting:
• AGM Letter to Shareholders; and
• Proxy Form.